schiff has invested in Ganeden Biotech, Inc.

Services
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
Acquisitions

Sales / Divestitures
Sectors
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
Aerospace & Defence

Agribusiness

Automotive

Business Services

Consumer Products
Energy & Mining

Food & Beverage

Healthcare & Pharmaceuticals

Industrials

Leisure
Maritime & Offshore

Packaging

Technology
Transactions
Advisors
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
Please, choose your cross-border team

REACH M&A Advisory Firms
About us
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
About

Organization

Insights

News

Contact

Experts who worked on this transaction

John R. Tilson

John R. Tilson

Managing Director & Principal at Brown Gibbons Lang & Company

Relevant transactions

Nordic Medcom

Physidia ASA

Nordic Medcom acquired by Physidia

Advisor to the seller :
Aventum Partners

Akodoc

Corman

Acodok and Corman merged through an asset contribution into the newly established NewCo, ClickSalute

Advisor :
Broletto Corporate Advisory

Apex Dental Lab

LongueVue Capital

Apex Dental Laboratory Group has completed a majority recapitalization with LongueVue Capital

Advisor to the seller :
Brown Gibbons Lang & Company

Otofarma

Otofarma has successfully completed its listing on the Euronext Growth Milan market

Advisor :
Broletto Corporate Advisory